AeroVironment division UES has received a $25-million contract to support the US Air Force Research Laboratory in developing human health and performance capabilities.
Under the three-year agreement, the company will work with the service’s 711th Human Performance Wing Human Effectiveness Directorate (711 HPW) to advance mid-stage sensor, diagnostic, and materials technologies from research into operational use.
The company will leverage in-house prototyping and AI-enabled data analytics to test and mature solutions for deployment, with the goal of improving “readiness, resilience, and survivability” for troops.
From Studies to Frontlines
Work will focus on aircraft and pilot sensors that track physiological and environmental data, along with ruggedized diagnostic wearables for medical, chemical, and biological assessment in complex operational environments.
It will also include AI and machine learning tools designed to convert biosensor data into actionable insights.
In addition, the effort will explore biotechnology platforms such as synthetic biology-engineered probiotics and sensors designed to support stress regulation.
AeroVironment noted that the award builds on previous work with the 711 HPW, including the use of onboard oxygen monitoring sensors used to investigate unexplained physiological deviations observed in pilots.
“With stringent requirements, harsh operating environments, and limited access to specialized infrastructure, health-focused devices for our military service members have faced unique challenges in reaching operational use,” said Dr. Stephaney Shanks, vice president of health and performance technologies at AeroVironment.
“AV has the tools, track record, and technical expertise to tackle these challenges with solutions that deliver real-world impact, using the power of science to protect and empower our warfighters,” Shanks stated.
